nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2C8—Mometasone—systemic scleroderma	0.167	0.468	CbGbCtD
Zopiclone—CYP2C9—Leflunomide—systemic scleroderma	0.0751	0.21	CbGbCtD
Zopiclone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0665	0.186	CbGbCtD
Zopiclone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.027	0.0755	CbGbCtD
Zopiclone—CYP3A4—Prednisone—systemic scleroderma	0.0216	0.0604	CbGbCtD
Zopiclone—CYP2C9—cardial valve—systemic scleroderma	0.0188	0.34	CbGeAlD
Zopiclone—TSPO—artery—systemic scleroderma	0.00463	0.0837	CbGeAlD
Zopiclone—TSPO—blood vessel—systemic scleroderma	0.00361	0.0652	CbGeAlD
Zopiclone—PTGS1—artery—systemic scleroderma	0.00258	0.0466	CbGeAlD
Zopiclone—PTGS1—endothelium—systemic scleroderma	0.00218	0.0393	CbGeAlD
Zopiclone—PTGS1—blood vessel—systemic scleroderma	0.00201	0.0363	CbGeAlD
Zopiclone—TSPO—connective tissue—systemic scleroderma	0.00185	0.0334	CbGeAlD
Zopiclone—TSPO—smooth muscle tissue—systemic scleroderma	0.00169	0.0306	CbGeAlD
Zopiclone—GABRB3—connective tissue—systemic scleroderma	0.00168	0.0304	CbGeAlD
Zopiclone—TSPO—skin of body—systemic scleroderma	0.00167	0.0302	CbGeAlD
Zopiclone—TSPO—digestive system—systemic scleroderma	0.00134	0.0241	CbGeAlD
Zopiclone—GABRB2—lung—systemic scleroderma	0.00132	0.0238	CbGeAlD
Zopiclone—TSPO—tendon—systemic scleroderma	0.00127	0.023	CbGeAlD
Zopiclone—TSPO—lung—systemic scleroderma	0.00112	0.0202	CbGeAlD
Zopiclone—PTGS1—connective tissue—systemic scleroderma	0.00103	0.0186	CbGeAlD
Zopiclone—GABRB3—lung—systemic scleroderma	0.00101	0.0183	CbGeAlD
Zopiclone—PTGS1—smooth muscle tissue—systemic scleroderma	0.000941	0.017	CbGeAlD
Zopiclone—PTGS1—skin of body—systemic scleroderma	0.000929	0.0168	CbGeAlD
Zopiclone—CYP2C9—digestive system—systemic scleroderma	0.000814	0.0147	CbGeAlD
Zopiclone—CYP2E1—digestive system—systemic scleroderma	0.000771	0.0139	CbGeAlD
Zopiclone—PTGS1—digestive system—systemic scleroderma	0.000743	0.0134	CbGeAlD
Zopiclone—CYP2E1—tendon—systemic scleroderma	0.000734	0.0133	CbGeAlD
Zopiclone—PTGS1—tendon—systemic scleroderma	0.000707	0.0128	CbGeAlD
Zopiclone—CYP2E1—lung—systemic scleroderma	0.000644	0.0116	CbGeAlD
Zopiclone—CYP3A4—digestive system—systemic scleroderma	0.000621	0.0112	CbGeAlD
Zopiclone—PTGS1—lung—systemic scleroderma	0.000621	0.0112	CbGeAlD
Zopiclone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000359	0.000612	CcSEcCtD
Zopiclone—Osteoarthritis—Methotrexate—systemic scleroderma	0.000359	0.000611	CcSEcCtD
Zopiclone—Confusional state—Lisinopril—systemic scleroderma	0.000358	0.00061	CcSEcCtD
Zopiclone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000358	0.000609	CcSEcCtD
Zopiclone—Headache—Mometasone—systemic scleroderma	0.000358	0.000609	CcSEcCtD
Zopiclone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000357	0.000608	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000357	0.000607	CcSEcCtD
Zopiclone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000357	0.000607	CcSEcCtD
Zopiclone—Fatigue—Leflunomide—systemic scleroderma	0.000356	0.000607	CcSEcCtD
Zopiclone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000355	0.000605	CcSEcCtD
Zopiclone—Pruritus—Captopril—systemic scleroderma	0.000355	0.000604	CcSEcCtD
Zopiclone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000354	0.000603	CcSEcCtD
Zopiclone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000602	CcSEcCtD
Zopiclone—Constipation—Leflunomide—systemic scleroderma	0.000353	0.000602	CcSEcCtD
Zopiclone—Pain—Leflunomide—systemic scleroderma	0.000353	0.000602	CcSEcCtD
Zopiclone—Infection—Lisinopril—systemic scleroderma	0.000353	0.000601	CcSEcCtD
Zopiclone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000352	0.0006	CcSEcCtD
Zopiclone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000351	0.000598	CcSEcCtD
Zopiclone—Somnolence—Mycophenolic acid—systemic scleroderma	0.00035	0.000597	CcSEcCtD
Zopiclone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000596	CcSEcCtD
Zopiclone—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000593	CcSEcCtD
Zopiclone—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000347	0.000591	CcSEcCtD
Zopiclone—Tachycardia—Lisinopril—systemic scleroderma	0.000347	0.00059	CcSEcCtD
Zopiclone—Body temperature increased—Azathioprine—systemic scleroderma	0.000346	0.000589	CcSEcCtD
Zopiclone—Abdominal pain—Azathioprine—systemic scleroderma	0.000346	0.000589	CcSEcCtD
Zopiclone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000585	CcSEcCtD
Zopiclone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000343	0.000584	CcSEcCtD
Zopiclone—Diarrhoea—Captopril—systemic scleroderma	0.000343	0.000584	CcSEcCtD
Zopiclone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000343	0.000583	CcSEcCtD
Zopiclone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000583	CcSEcCtD
Zopiclone—Irritability—Methotrexate—systemic scleroderma	0.000342	0.000583	CcSEcCtD
Zopiclone—Erectile dysfunction—Prednisone—systemic scleroderma	0.000342	0.000582	CcSEcCtD
Zopiclone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000341	0.00058	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00034	0.000579	CcSEcCtD
Zopiclone—Fatigue—Mycophenolic acid—systemic scleroderma	0.00034	0.000579	CcSEcCtD
Zopiclone—Mood swings—Methotrexate—systemic scleroderma	0.00034	0.000578	CcSEcCtD
Zopiclone—Nausea—Mometasone—systemic scleroderma	0.000339	0.000577	CcSEcCtD
Zopiclone—Anorexia—Lisinopril—systemic scleroderma	0.000338	0.000576	CcSEcCtD
Zopiclone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000338	0.000575	CcSEcCtD
Zopiclone—Weight increased—Prednisone—systemic scleroderma	0.000338	0.000575	CcSEcCtD
Zopiclone—Ataxia—Methotrexate—systemic scleroderma	0.000337	0.000574	CcSEcCtD
Zopiclone—Pain—Mycophenolic acid—systemic scleroderma	0.000337	0.000574	CcSEcCtD
Zopiclone—Constipation—Mycophenolic acid—systemic scleroderma	0.000337	0.000574	CcSEcCtD
Zopiclone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000574	CcSEcCtD
Zopiclone—Weight decreased—Prednisone—systemic scleroderma	0.000336	0.000571	CcSEcCtD
Zopiclone—Dizziness—Captopril—systemic scleroderma	0.000332	0.000565	CcSEcCtD
Zopiclone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000562	CcSEcCtD
Zopiclone—Depression—Prednisone—systemic scleroderma	0.00033	0.000561	CcSEcCtD
Zopiclone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000329	0.00056	CcSEcCtD
Zopiclone—Urticaria—Leflunomide—systemic scleroderma	0.000328	0.000559	CcSEcCtD
Zopiclone—Abdominal pain—Leflunomide—systemic scleroderma	0.000327	0.000556	CcSEcCtD
Zopiclone—Body temperature increased—Leflunomide—systemic scleroderma	0.000327	0.000556	CcSEcCtD
Zopiclone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000325	0.000553	CcSEcCtD
Zopiclone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000553	CcSEcCtD
Zopiclone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000553	CcSEcCtD
Zopiclone—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000324	0.000552	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000324	0.000551	CcSEcCtD
Zopiclone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000323	0.000551	CcSEcCtD
Zopiclone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000322	0.000549	CcSEcCtD
Zopiclone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000322	0.000549	CcSEcCtD
Zopiclone—Insomnia—Lisinopril—systemic scleroderma	0.000321	0.000547	CcSEcCtD
Zopiclone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000546	CcSEcCtD
Zopiclone—Paraesthesia—Lisinopril—systemic scleroderma	0.000319	0.000543	CcSEcCtD
Zopiclone—Vomiting—Captopril—systemic scleroderma	0.000319	0.000543	CcSEcCtD
Zopiclone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000317	0.00054	CcSEcCtD
Zopiclone—Dyspnoea—Lisinopril—systemic scleroderma	0.000317	0.000539	CcSEcCtD
Zopiclone—Rash—Captopril—systemic scleroderma	0.000316	0.000538	CcSEcCtD
Zopiclone—Dermatitis—Captopril—systemic scleroderma	0.000316	0.000538	CcSEcCtD
Zopiclone—Somnolence—Lisinopril—systemic scleroderma	0.000316	0.000537	CcSEcCtD
Zopiclone—Headache—Captopril—systemic scleroderma	0.000314	0.000535	CcSEcCtD
Zopiclone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000534	CcSEcCtD
Zopiclone—Dyspepsia—Lisinopril—systemic scleroderma	0.000313	0.000532	CcSEcCtD
Zopiclone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000312	0.000531	CcSEcCtD
Zopiclone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000312	0.000531	CcSEcCtD
Zopiclone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000311	0.00053	CcSEcCtD
Zopiclone—Asthma—Methotrexate—systemic scleroderma	0.00031	0.000528	CcSEcCtD
Zopiclone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000526	CcSEcCtD
Zopiclone—Decreased appetite—Lisinopril—systemic scleroderma	0.000309	0.000526	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000307	0.000522	CcSEcCtD
Zopiclone—Fatigue—Lisinopril—systemic scleroderma	0.000306	0.000521	CcSEcCtD
Zopiclone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000304	0.000518	CcSEcCtD
Zopiclone—Pain—Lisinopril—systemic scleroderma	0.000304	0.000517	CcSEcCtD
Zopiclone—Constipation—Lisinopril—systemic scleroderma	0.000304	0.000517	CcSEcCtD
Zopiclone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000517	CcSEcCtD
Zopiclone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000512	CcSEcCtD
Zopiclone—Diarrhoea—Azathioprine—systemic scleroderma	0.000299	0.00051	CcSEcCtD
Zopiclone—Nausea—Captopril—systemic scleroderma	0.000298	0.000507	CcSEcCtD
Zopiclone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000505	CcSEcCtD
Zopiclone—Asthenia—Leflunomide—systemic scleroderma	0.000296	0.000505	CcSEcCtD
Zopiclone—Hallucination—Prednisone—systemic scleroderma	0.000295	0.000503	CcSEcCtD
Zopiclone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000293	0.000498	CcSEcCtD
Zopiclone—Pruritus—Leflunomide—systemic scleroderma	0.000292	0.000498	CcSEcCtD
Zopiclone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00029	0.000494	CcSEcCtD
Zopiclone—Dysuria—Methotrexate—systemic scleroderma	0.00029	0.000493	CcSEcCtD
Zopiclone—Dizziness—Azathioprine—systemic scleroderma	0.000289	0.000493	CcSEcCtD
Zopiclone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000285	0.000486	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000483	CcSEcCtD
Zopiclone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000283	0.000482	CcSEcCtD
Zopiclone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000283	0.000482	CcSEcCtD
Zopiclone—Diarrhoea—Leflunomide—systemic scleroderma	0.000283	0.000481	CcSEcCtD
Zopiclone—Urticaria—Lisinopril—systemic scleroderma	0.000282	0.00048	CcSEcCtD
Zopiclone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000479	CcSEcCtD
Zopiclone—Abdominal pain—Lisinopril—systemic scleroderma	0.000281	0.000478	CcSEcCtD
Zopiclone—Body temperature increased—Lisinopril—systemic scleroderma	0.000281	0.000478	CcSEcCtD
Zopiclone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000476	CcSEcCtD
Zopiclone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000279	0.000475	CcSEcCtD
Zopiclone—Vomiting—Azathioprine—systemic scleroderma	0.000278	0.000474	CcSEcCtD
Zopiclone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000472	CcSEcCtD
Zopiclone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000471	CcSEcCtD
Zopiclone—Drowsiness—Methotrexate—systemic scleroderma	0.000276	0.00047	CcSEcCtD
Zopiclone—Rash—Azathioprine—systemic scleroderma	0.000276	0.00047	CcSEcCtD
Zopiclone—Dermatitis—Azathioprine—systemic scleroderma	0.000276	0.000469	CcSEcCtD
Zopiclone—Depression—Methotrexate—systemic scleroderma	0.000276	0.000469	CcSEcCtD
Zopiclone—Headache—Azathioprine—systemic scleroderma	0.000274	0.000467	CcSEcCtD
Zopiclone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000274	0.000466	CcSEcCtD
Zopiclone—Dizziness—Leflunomide—systemic scleroderma	0.000273	0.000465	CcSEcCtD
Zopiclone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00046	CcSEcCtD
Zopiclone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00027	0.000459	CcSEcCtD
Zopiclone—Stomatitis—Methotrexate—systemic scleroderma	0.000269	0.000459	CcSEcCtD
Zopiclone—Conjunctivitis—Methotrexate—systemic scleroderma	0.000269	0.000457	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000457	CcSEcCtD
Zopiclone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000453	CcSEcCtD
Zopiclone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000453	CcSEcCtD
Zopiclone—Sweating—Methotrexate—systemic scleroderma	0.000265	0.000451	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—systemic scleroderma	0.000263	0.000449	CcSEcCtD
Zopiclone—Vomiting—Leflunomide—systemic scleroderma	0.000263	0.000447	CcSEcCtD
Zopiclone—Alopecia—Prednisone—systemic scleroderma	0.000262	0.000447	CcSEcCtD
Zopiclone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000262	0.000445	CcSEcCtD
Zopiclone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000261	0.000444	CcSEcCtD
Zopiclone—Epistaxis—Methotrexate—systemic scleroderma	0.000261	0.000444	CcSEcCtD
Zopiclone—Rash—Leflunomide—systemic scleroderma	0.000261	0.000444	CcSEcCtD
Zopiclone—Dermatitis—Leflunomide—systemic scleroderma	0.00026	0.000443	CcSEcCtD
Zopiclone—Nausea—Azathioprine—systemic scleroderma	0.00026	0.000443	CcSEcCtD
Zopiclone—Headache—Leflunomide—systemic scleroderma	0.000259	0.000441	CcSEcCtD
Zopiclone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000436	CcSEcCtD
Zopiclone—Asthenia—Lisinopril—systemic scleroderma	0.000255	0.000434	CcSEcCtD
Zopiclone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000433	CcSEcCtD
Zopiclone—Pruritus—Lisinopril—systemic scleroderma	0.000251	0.000428	CcSEcCtD
Zopiclone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000251	0.000427	CcSEcCtD
Zopiclone—Rash—Mycophenolic acid—systemic scleroderma	0.000249	0.000423	CcSEcCtD
Zopiclone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000248	0.000423	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—systemic scleroderma	0.000248	0.000422	CcSEcCtD
Zopiclone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000421	CcSEcCtD
Zopiclone—Headache—Mycophenolic acid—systemic scleroderma	0.000247	0.00042	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—systemic scleroderma	0.000246	0.000419	CcSEcCtD
Zopiclone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000419	CcSEcCtD
Zopiclone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000419	CcSEcCtD
Zopiclone—Nausea—Leflunomide—systemic scleroderma	0.000245	0.000418	CcSEcCtD
Zopiclone—Vision blurred—Prednisone—systemic scleroderma	0.000244	0.000415	CcSEcCtD
Zopiclone—Diarrhoea—Lisinopril—systemic scleroderma	0.000243	0.000414	CcSEcCtD
Zopiclone—Ill-defined disorder—Prednisone—systemic scleroderma	0.00024	0.000408	CcSEcCtD
Zopiclone—Anaemia—Prednisone—systemic scleroderma	0.000239	0.000407	CcSEcCtD
Zopiclone—Agitation—Prednisone—systemic scleroderma	0.000237	0.000404	CcSEcCtD
Zopiclone—Angioedema—Prednisone—systemic scleroderma	0.000236	0.000402	CcSEcCtD
Zopiclone—Dizziness—Lisinopril—systemic scleroderma	0.000235	0.0004	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000235	0.000399	CcSEcCtD
Zopiclone—Nausea—Mycophenolic acid—systemic scleroderma	0.000234	0.000399	CcSEcCtD
Zopiclone—Malaise—Prednisone—systemic scleroderma	0.000233	0.000397	CcSEcCtD
Zopiclone—Vertigo—Prednisone—systemic scleroderma	0.000232	0.000395	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—systemic scleroderma	0.000231	0.000394	CcSEcCtD
Zopiclone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00039	CcSEcCtD
Zopiclone—Vomiting—Lisinopril—systemic scleroderma	0.000226	0.000384	CcSEcCtD
Zopiclone—Rash—Lisinopril—systemic scleroderma	0.000224	0.000381	CcSEcCtD
Zopiclone—Convulsion—Prednisone—systemic scleroderma	0.000224	0.000381	CcSEcCtD
Zopiclone—Dermatitis—Lisinopril—systemic scleroderma	0.000224	0.000381	CcSEcCtD
Zopiclone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000223	0.00038	CcSEcCtD
Zopiclone—Hypertension—Prednisone—systemic scleroderma	0.000223	0.00038	CcSEcCtD
Zopiclone—Chills—Methotrexate—systemic scleroderma	0.000223	0.000379	CcSEcCtD
Zopiclone—Headache—Lisinopril—systemic scleroderma	0.000222	0.000379	CcSEcCtD
Zopiclone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000375	CcSEcCtD
Zopiclone—Myalgia—Prednisone—systemic scleroderma	0.00022	0.000375	CcSEcCtD
Zopiclone—Anxiety—Prednisone—systemic scleroderma	0.000219	0.000373	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—systemic scleroderma	0.000219	0.000373	CcSEcCtD
Zopiclone—Discomfort—Prednisone—systemic scleroderma	0.000217	0.00037	CcSEcCtD
Zopiclone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000362	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—systemic scleroderma	0.000211	0.00036	CcSEcCtD
Zopiclone—Nausea—Lisinopril—systemic scleroderma	0.000211	0.000359	CcSEcCtD
Zopiclone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000211	0.000359	CcSEcCtD
Zopiclone—Infection—Prednisone—systemic scleroderma	0.00021	0.000357	CcSEcCtD
Zopiclone—Back pain—Methotrexate—systemic scleroderma	0.000209	0.000356	CcSEcCtD
Zopiclone—Tachycardia—Prednisone—systemic scleroderma	0.000206	0.00035	CcSEcCtD
Zopiclone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00035	CcSEcCtD
Zopiclone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000204	0.000347	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—systemic scleroderma	0.000204	0.000347	CcSEcCtD
Zopiclone—Anorexia—Prednisone—systemic scleroderma	0.000201	0.000342	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.0002	0.000341	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—systemic scleroderma	0.0002	0.00034	CcSEcCtD
Zopiclone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000337	CcSEcCtD
Zopiclone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000334	CcSEcCtD
Zopiclone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000334	CcSEcCtD
Zopiclone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000332	CcSEcCtD
Zopiclone—Malaise—Methotrexate—systemic scleroderma	0.000195	0.000332	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—systemic scleroderma	0.000194	0.00033	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000192	0.000327	CcSEcCtD
Zopiclone—Insomnia—Prednisone—systemic scleroderma	0.000191	0.000325	CcSEcCtD
Zopiclone—Paraesthesia—Prednisone—systemic scleroderma	0.000189	0.000322	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—systemic scleroderma	0.000187	0.000319	CcSEcCtD
Zopiclone—Dyspepsia—Prednisone—systemic scleroderma	0.000186	0.000316	CcSEcCtD
Zopiclone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000315	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—systemic scleroderma	0.000184	0.000313	CcSEcCtD
Zopiclone—Chest pain—Methotrexate—systemic scleroderma	0.000184	0.000313	CcSEcCtD
Zopiclone—Decreased appetite—Prednisone—systemic scleroderma	0.000183	0.000312	CcSEcCtD
Zopiclone—Fatigue—Prednisone—systemic scleroderma	0.000182	0.00031	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—systemic scleroderma	0.000182	0.000309	CcSEcCtD
Zopiclone—Constipation—Prednisone—systemic scleroderma	0.00018	0.000307	CcSEcCtD
Zopiclone—Confusional state—Methotrexate—systemic scleroderma	0.000178	0.000303	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000176	0.0003	CcSEcCtD
Zopiclone—Infection—Methotrexate—systemic scleroderma	0.000175	0.000298	CcSEcCtD
Zopiclone—Feeling abnormal—Prednisone—systemic scleroderma	0.000174	0.000296	CcSEcCtD
Zopiclone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000172	0.000294	CcSEcCtD
Zopiclone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00017	0.00029	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—systemic scleroderma	0.000168	0.000286	CcSEcCtD
Zopiclone—Urticaria—Prednisone—systemic scleroderma	0.000168	0.000285	CcSEcCtD
Zopiclone—Abdominal pain—Prednisone—systemic scleroderma	0.000167	0.000284	CcSEcCtD
Zopiclone—Body temperature increased—Prednisone—systemic scleroderma	0.000167	0.000284	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000161	0.000273	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—systemic scleroderma	0.000159	0.000271	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—systemic scleroderma	0.000158	0.000269	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—systemic scleroderma	0.000157	0.000268	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—systemic scleroderma	0.000157	0.000267	CcSEcCtD
Zopiclone—Hypersensitivity—Prednisone—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—systemic scleroderma	0.000155	0.000264	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—systemic scleroderma	0.000153	0.000261	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000152	0.000259	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—systemic scleroderma	0.000152	0.000259	CcSEcCtD
Zopiclone—Asthenia—Prednisone—systemic scleroderma	0.000151	0.000258	CcSEcCtD
Zopiclone—Pain—Methotrexate—systemic scleroderma	0.000151	0.000257	CcSEcCtD
Zopiclone—Pruritus—Prednisone—systemic scleroderma	0.000149	0.000254	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000145	0.000247	CcSEcCtD
Zopiclone—Diarrhoea—Prednisone—systemic scleroderma	0.000144	0.000246	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000144	0.000245	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—systemic scleroderma	0.00014	0.000238	CcSEcCtD
Zopiclone—Dizziness—Prednisone—systemic scleroderma	0.000139	0.000237	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—systemic scleroderma	0.000139	0.000237	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—systemic scleroderma	0.000139	0.000237	CcSEcCtD
Zopiclone—Vomiting—Prednisone—systemic scleroderma	0.000134	0.000228	CcSEcCtD
Zopiclone—Rash—Prednisone—systemic scleroderma	0.000133	0.000226	CcSEcCtD
Zopiclone—Dermatitis—Prednisone—systemic scleroderma	0.000133	0.000226	CcSEcCtD
Zopiclone—Headache—Prednisone—systemic scleroderma	0.000132	0.000225	CcSEcCtD
Zopiclone—Hypersensitivity—Methotrexate—systemic scleroderma	0.00013	0.000221	CcSEcCtD
Zopiclone—Asthenia—Methotrexate—systemic scleroderma	0.000126	0.000215	CcSEcCtD
Zopiclone—Nausea—Prednisone—systemic scleroderma	0.000125	0.000213	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—systemic scleroderma	0.000125	0.000212	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—systemic scleroderma	0.000121	0.000205	CcSEcCtD
Zopiclone—Dizziness—Methotrexate—systemic scleroderma	0.000117	0.000198	CcSEcCtD
Zopiclone—Vomiting—Methotrexate—systemic scleroderma	0.000112	0.000191	CcSEcCtD
Zopiclone—Rash—Methotrexate—systemic scleroderma	0.000111	0.000189	CcSEcCtD
Zopiclone—Dermatitis—Methotrexate—systemic scleroderma	0.000111	0.000189	CcSEcCtD
Zopiclone—Headache—Methotrexate—systemic scleroderma	0.00011	0.000188	CcSEcCtD
Zopiclone—Nausea—Methotrexate—systemic scleroderma	0.000105	0.000178	CcSEcCtD
